An exploratory study on99mTc-RGD-BBN peptide scintimammography in the assessment of breast malignant lesions compared to99mTc-3P4-RGD2

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Chen, Qianqian ^a   Ma, Qingjie ^a   Chen, Minglong ^a   Chen, Bin ^a   Wen, Qiang ^a   Jia, Bing ^b   Wang, Fan ^b   Sun, Butong ^a   Gao, Shi ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3P4 ARGINYLGLYCYLASPARTIC ACID 2 TC 99M; ARGINYLGLYCYLASPARTIC ACID BOMBESIN TC 99M; GASTRIN RELEASING PEPTIDE RECEPTOR; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; ARGINYL-GLYCYL-ASPARTIC ACID; OLIGOPEPTIDE; TECHNETIUM COMPLEX;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOSIMETRY; EXPLORATORY RESEARCH; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION SAFETY; RADIOACTIVITY; RADIOISOTOPE DISTRIBUTION; SCINTIMAMMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BREAST TUMOR; CASE CONTROL STUDY; CHEMISTRY; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; MAMMOGRAPHY; METABOLISM; MIDDLE AGED; NORMAL HUMAN; PATHOLOGY; PROCEDURES; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HEALTHY VOLUNTEERS; HUMANS; MALE; MAMMOGRAPHY; MIDDLE AGED; OLIGOPEPTIDES; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84927590158     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123401     Document Type: Article

References (27)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: a cancer journal for clinicians. 2012; 62: 10-29. doi: 10.3322/caac.20138 PMID: 22237781
2. DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA: a cancer journal for clinicians. 2011; 61: 408-418. doi: 10.3322/caac.20125 PMID: 22086728
3. Okarvi S. Peptide-based radiopharmaceuticals: Future tools for diagnostic imaging of cancers and other diseases. Medicinal research reviews. 2004; 24: 357-397. PMID: 14994368
4. Ma Q, Ji B, Jia B, Gao S, Ji T, Wang X, et al. Differential diagnosis of solitary pulmonary nodules using 99mTc-3P4-RGD2 scintigraphy. European journal of nuclear medicine and molecular imaging. 2011; 38: 2145-2152. doi: 10.1007/s00259-011-1901-2 PMID: 21874323
5. Guanghui C, Shi G, Tiefeng J, Qingjie M, Bing J, Zuowei C, et al. Pharmacokinetics and radiation dosimetry of ∼(99m) Tc-3PRGD-2 in healthy individuals: A pilot study. Nuclear Science and Techniques. 2012; 23: 349-349-354.
6. Zhu Z, Miao W, Li Q, Dai H, Ma Q, Wang F, et al. 99mTc-3PRGD2 for integrin receptor imaging of lung cancer: a multicenter study. Journal of Nuclear Medicine. 2012; 53: 716-722. doi: 10.2967/jnumed.111.098988 PMID: 22499615
7. Ji S, Zheng Y, Shao G, Zhou Y, Liu S. Integrin αvβ3-Targeted Radiotracer 99mTc-3P-RGD2 Useful for Noninvasive Monitoring of Breast Tumor Response to Antiangiogenic Linifanib Therapy but not Anti-Integrin αvβ3 RGD2 Therapy. Theranostics. 2013; 3: 816. doi: 10.7150/thno.6989 PMID: 24312152
8. Liu Z, Yan Y, Liu S, Wang F, Chen X. 18F, 64Cu, and 68Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer. Bioconjugate chemistry. 2009; 20: 1016-1025. doi: 10.1021/bc9000245 PMID: 20540537
9. Liu Z, Huang J, Dong C, Cui L, Jin X, Jia B, et al. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma. Molecular pharmaceutics. 2012; 9: 1409-1417. doi: 10.1021/mp200661t PMID: 22452411
10. Liu Z, Niu G, Wang F, Chen X. 68Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging. European journal of nuclear medicine and molecular imaging. 2009; 36: 1483-1494. doi: 10.1007/s00259-009-1123-z PMID: 19360404
11. Scott N, Millward E, Cartwright E, Preston S, Coletta P. Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours. Journal of clinical pathology. 2004; 57: 189-192. PMID: 14747448
12. Wiegrebe L. An autocorrelation model of bat sonar. Biol. Cybern. 2008; 98: 587-595. doi: 10.1007/s00422-008-0216-2 PMID: 18491168
13. Yu Z, Ananias HJ, Carlucci G, Hoving HD, Helfrich W, Dierckx RA, et al. An update of radiolabeled bombesin analogs for gastrin-releasing peptide receptor targeting. Current pharmaceutical design. 2013; 19: 3329-3341. PMID: 23431995
14. Liu S, Hsieh W, Jiang Y, Kim Y, Sreerama SG, Chen X, et al. Evaluation of a 99mTc-labeled cyclic RGD tetramer for noninvasive imaging integrin αvβ3-positive breast cancer. Bioconjugate chemistry. 2007; 18: 438-446. PMID: 17341108
15. Beer AJ, Grosu A, Carlsen J, Kolk A, Sarbia M, Stangier I, et al. [18F] galacto-RGD positron emission tomography for imaging of αvβ3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck. Clinical Cancer Research. 2007; 13: 6610-6616. PMID: 18006761
16. Beer AJ, Haubner R, Sarbia M, Goebel M, Luderschmidt S, Grosu AL, et al. Positron emission tomography using [18F] Galacto-RGD identifies the level of integrin αvβ3 expression in man. Clinical Cancer Research. 2006; 12: 3942-3949. PMID: 16818691
17. Zhang X, Cai W, Cao F, Schreibmann E, Wu Y, Wu JC, et al. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. Journal of Nuclear Medicine. 2006; 47: 492-501. PMID: 16513619
18. 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma. Nuclear medicine and biology. 2006; 33: 371-380. PMID: 16631086
19. Aitmohand S, Fournier P, Dumulonperreault V, Kiefer GE, Jurek P, Ferreira CL, et al. Evaluation of 64Cu-labeled bifunctional chelate - bombesin conjugates. Bioconjugate chemistry. 2011; 22: 1729-1735. doi: 10.1021/bc2002665 PMID: 21761921
20. Marrone B, Meurer L, Moretto A, Kleina W, Schwartsmann G. Expression of gastrin-releasing peptide receptor in patients with cutaneous malignant melanoma. Clinical and experimental dermatology. 2013; 38: 707-712. doi: 10.1111/ced.12058 PMID: 23581973
21. de Visser M, van Weerden WM, de Ridder CM, Reneman S, Melis M, Krenning EP, et al. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts. Journal of nuclear medicine: official publication, Society of Nuclear Medicine. 2007; 48: 88-93.
22. Protection TRotICoR. ICRP publication 103. Annals of the ICRP. 2007; 37: 1-332. doi: 10.1016/j.icrp.2008.08.001 PMID: 18762065
23. Kehoe T. International Commission on Radiological Protection publications 97 and 98: radiation protection can be fun! Clinical Oncology. 2007; 19: 539-541. PMID: 17604971
24. Pradhan AS. Evolution of dosimetric quantities of International Commission on Radiological Protection (ICRP): Impact of the forthcoming recommendations. Journal of medical physics / Association of Medical Physicists of India. 2007; 32: 89-91. doi: 10.4103/0971-6203.35719 PMID: 21157526
25. Kubo A, Nakamura K, Sanmiya T, Shimizu S, Hashimoto S, Iwanaga S, et al. [Phase I clinical study on 99mTc-MIBI]. Kaku igaku. The Japanese journal of nuclear medicine. 1991; 28: 1133-1142. PMID: 1839318
26. Liu L, Song Y, Gao S, Ji T, Zhang H, Ji B, et al. (99)mTc-3PRGD2 scintimammography in palpable and nonpalpable breast lesions. Molecular imaging. 2014; 13.
27. Strande V, Canelle L, Tastet C, Burletschiltz O, Monsarrat B, Hondermarck H. The proteome of the human breast cancer cell line MDA-MB-231: Analysis by LTQ-Orbitrap mass spectrometry. PROTEO-MICS-Clinical Applications. 2009; 3: 41-50. doi: 10.1002/prca.200800083 PMID: 21136935